Nu Holdings stock: NU hovers near $17 ahead of Nubank earnings as rates, Brazil headlines bite

Nu Holdings stock: NU hovers near $17 ahead of Nubank earnings as rates, Brazil headlines bite

February 19, 2026

New York, Feb 19, 2026, 07:51 EST — Premarket

  • Nu Holdings ticked a bit higher before the bell, building on a 2% gain from the previous session.
  • Nubank’s parent has quarterly earnings on deck for next week.
  • Investors sift through Fed minutes, with eyes now turning to Friday’s U.S. inflation numbers.

Nu Holdings Ltd edged up around 0.1% to $17.19 in premarket action Thursday, after a close at $17.17 on Wednesday—good for a 2% rise. Over the last year, shares have traded between $9.01 and $18.98.

NU stays rangebound heading into a crucial week for the stock. Investors want new details on loan growth, funding costs, and how credit quality is holding up as the company pushes past Brazil.

Nu plans to release its fourth-quarter 2025 earnings after the U.S. market wraps on Feb. 25. The conference call gets underway at 5 p.m. ET.

Markets looked twitchy. U.S. stock index futures slipped early Thursday, with investors on edge over the uncertain returns from big AI investments and casting an eye toward Walmart’s earnings. The latest Fed minutes revealed officials mostly favored a rate pause but split over future moves; “the bias will be toward keeping interest rates on hold,” Oxford Economics lead U.S. economist Bernard Yaros wrote. Reuters

Nu’s core business is still anchored in Brazil, and shifts in the local banking landscape can quickly move the needle on sentiment. On Wednesday, Brazil’s central bank stepped in to order the extrajudicial liquidation of Banco Pleno, a smaller player in the sector, after flagging its weak finances and liquidity troubles, along with regulatory noncompliance. The central bank deploys extrajudicial liquidation—a process that bypasses the courts—when it determines a lender can’t stay afloat.

Nu runs its digital banking business mostly through the Nubank brand, anchored in Brazil, while also expanding in Mexico and Colombia. The stock, as a result, rides the swings of local credit conditions along with shifts in global risk appetite.

Earnings ahead: traders are zeroing in on delinquency shifts, how much firms are setting aside for loan losses, and the speed of unsecured loan growth. Also on the radar—funding costs. Are they finally coming down, or staying stubborn? It’s a big margin lever for consumer lenders.

Expectations are a factor here, too. NU’s stock still sits much nearer its highs than its lows, so even a slight earnings miss—or any hint of caution around credit—can weigh on shares that have been behaving like a growth play.

The risk is clear enough: should Brazil’s economy lose steam faster than anticipated or credit expenses climb, shares could slip despite a healthy pace of customer growth. Currency swings? They tend to muddy both earnings and how investors interpret them.

Artur Ślesik

Artur Ślesik is a technology and financial markets journalist at Bez-kabli.pl, covering artificial intelligence, semiconductors, technology stocks and emerging innovations. A graduate of Warsaw University of Technology, he combines a technical background with market analysis to explain how new technologies are shaping industries, businesses and investment trends worldwide.

Stock Market Today

  • Qantas (ASX:QAN) dips, ResMed (ASX:RMD) lags 52-week high as FY24 numbers show contrast
    July 10, 2026, 5:04 PM EDT. Qantas Airways Ltd (ASX:QAN) dropped 0.8% in early 2025 trade. ResMed (ASX:RMD) is still down 33.6% from its 52-week high. Qantas has posted strong gains since 2021. Revenue jumped 54.6% year-on-year to $21.9 billion in FY24, net profit flipped positive at $1.25 billion, and return on equity (ROE) reached 823%. ResMed, in sleep apnea and health tech, saw revenue up 13.6% to $4.7 billion, net profit at $1.02 billion, and ROE of 22.7% for FY24. Investors looking at both names are watching the fundamentals but will want to check valuations from here.